ArticleOncotarget2016

Phase I trial evaluating the antiviral agent Cidofovir in combination with chemoradiation in cervical cancer patients.

Eric Deutsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.